The VROOM trial looked at the effect of interrupting methotrexate treatment for two-weeks after taking COVID-19 booster in adults with autoimmune conditions.
from Medindia Health News https://ift.tt/gWq4TVt
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
June 29, 2022
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.